Improving antiplatelet therapy uptake: lessons from the Scottish experience

Cardiovascular disease remains the leading cause of death worldwide.1,2 Advances in management strategies have, however, reduced population-level mortality rates for certain cardiovascular conditions over the past several decades, such as for coronary artery disease.3 As part of these advances, the use of effective therapies such as antiplatelet therapies (APT) has increased substantially over time in […]

Read More…

Featured Content